251 related articles for article (PubMed ID: 34437781)
1. Percutaneous Closure of a Cribriform Secundum Atrial Septal Defect and Patent Foramen Ovale.
Wilson J; Oberoi M; Stys T; Stys A
S D Med; 2021 May; 74(5):227-229. PubMed ID: 34437781
[TBL] [Abstract][Full Text] [Related]
2. Closure of a coexisting ostium secundum atrial septal defect and patent foramen ovale using a single Amplatzer patent foramen ovale occluder device.
Luna M; Banerjee S; Brilakis ES
Cardiovasc Revasc Med; 2010; 11(1):63-6. PubMed ID: 20129363
[TBL] [Abstract][Full Text] [Related]
3. Transcatheter Closure of Atrial Septal Defect: A Review of Currently Used Devices.
Shrivastava S; Shrivastava S; Allu SVV; Schmidt P
Cureus; 2023 Jun; 15(6):e40132. PubMed ID: 37425612
[TBL] [Abstract][Full Text] [Related]
4. Simplified percutaneous closure of patent foramen ovale and atrial septal defect with use of plain fluoroscopy: Single operator experience in 110 consecutive patients.
Manolis AS; Koulouris S; Rouska E; Pyrros J
Indian Heart J; 2018; 70(1):24-31. PubMed ID: 29455783
[TBL] [Abstract][Full Text] [Related]
5. Impact of Percutaneous Closure of Interatrial Shunts on Migraine Attacks: Single-Operator Series and Review of the Literature.
Manolis AS
Rev Recent Clin Trials; 2017; 12(2):129-138. PubMed ID: 28356032
[TBL] [Abstract][Full Text] [Related]
6. Transcatheter Closure of Patent Foramen Ovale: Devices and Technique.
Price MJ
Interv Cardiol Clin; 2017 Oct; 6(4):555-567. PubMed ID: 28886846
[TBL] [Abstract][Full Text] [Related]
7. Clinical Experience of Percutaneous Patent Foramen Ovale Closure Using the Amplatzer PFO Occluder in Japanese Patients to Prevent the Recurrence of Cryptogenic Stroke.
Takafuji H; Obunai K; Makihara Y; Kato N; Watanabe H
Intern Med; 2021 Nov; 60(21):3385-3390. PubMed ID: 34024855
[TBL] [Abstract][Full Text] [Related]
8. Transcatheter interatrial septal defect closure in a large cohort: midterm follow-up results.
Aytemir K; Oto A; Özkutlu S; Canpolat U; Kaya EB; Yorgun H; Şahiner L; Sunman H; Ateş AH; Kabakçı G
Congenit Heart Dis; 2013; 8(5):418-27. PubMed ID: 23601507
[TBL] [Abstract][Full Text] [Related]
9. Application of Transesophageal Echocardiography in Amplatzer Atrial Septal Defect Occluder for Percutaneous Closure of Large Patent Foramen Ovale.
Du Y; Xie H; Shao H; Cheng G; He L; Wang X; He X; Lan B; Zhang Y; Tian G
Cardiovasc Ther; 2022; 2022():3226080. PubMed ID: 35936794
[TBL] [Abstract][Full Text] [Related]
10. Patent foramen ovale with complex anatomy: Comparison of two different devices (Amplatzer Septal Occluder device and Amplatzer PFO Occluder device 30/35).
Giordano M; Gaio G; Santoro G; Palladino MT; Sarubbi B; Golino P; Russo MG
Int J Cardiol; 2019 Mar; 279():47-50. PubMed ID: 30344060
[TBL] [Abstract][Full Text] [Related]
11. Medium-term results of transcatheter closure of patent foramen ovale (PFO) with Amplatzer PFO and Cribriform occluders.
Białkowski J; Wawrzyńczyk M; Karwot B; Fiszer R; Knop M; Szkutnik M
Kardiol Pol; 2012; 70(11):1142-6. PubMed ID: 23180522
[TBL] [Abstract][Full Text] [Related]
12. Comparison of residual shunt rate and complications across 6 different closure devices for patent foramen ovale.
Gevorgyan Fleming R; Kumar P; West B; Noureddin N; Rusheen J; Aboulhosn J; Tobis JM
Catheter Cardiovasc Interv; 2020 Feb; 95(3):365-372. PubMed ID: 31654558
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous closure of inter-atrial communications (atrial septal defect and patent foramen ovale): single-centre experience and mid-term follow-up.
Van de Bruaene A; Stroobants D; Benit E
Acta Cardiol; 2015 Apr; 70(2):133-40. PubMed ID: 26148372
[TBL] [Abstract][Full Text] [Related]
14. Comparison of residual shunt rates in five devices used to treat patent foramen ovale.
Matsumura K; Gevorgyan R; Mangels D; Masoomi R; Mojadidi MK; Tobis J
Catheter Cardiovasc Interv; 2014 Sep; 84(3):455-63. PubMed ID: 24550064
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous closure of atrial septal defects: immediate and mid-term results.
Dardas PS; Ninios VN; Mezilis NE; Tsikaderis DD; Thanopoulos VD
Hellenic J Cardiol; 2010; 51(2):104-12. PubMed ID: 20378511
[TBL] [Abstract][Full Text] [Related]
16. A Comparison Between Gore Cardioform and Amplatzer Septal Occluder for Percutaneous Closure of Patent Foramen Ovale Associated With Atrial Septal Aneurysm: Clinical and Echocardiographic Outcomes.
Musto C; Cifarelli A; Dipasquale F; Chin D; Nazzaro MS; Stio RE; Pennacchi M; De Felice F
J Invasive Cardiol; 2021 Nov; 33(11):E857-E862. PubMed ID: 34653958
[TBL] [Abstract][Full Text] [Related]
17. Atrial septal defect and patent foramen ovale: early and long-term effects on endothelial function after percutaneous occlusion procedure.
Scicchitano P; Gesualdo M; Cortese F; Acquaviva T; de Cillis E; Bortone AS; Ciccone MM
Heart Vessels; 2019 Sep; 34(9):1499-1508. PubMed ID: 30895384
[TBL] [Abstract][Full Text] [Related]
18. Amplatzer occluder versus CardioSEAL/STARFlex occluder: a meta-analysis of the efficacy and safety of transcatheter occlusion for patent foramen ovale and atrial septal defect.
Li Y; Zhou K; Hua Y; Wang C; Xie L; Fang J; Rong X; Shen J
Cardiol Young; 2013 Aug; 23(4):582-96. PubMed ID: 23199453
[TBL] [Abstract][Full Text] [Related]
19. Patent Foramen Ovale and Atrial Septal Defect.
Aoun J; Hatab T; Volpi J; Lin CH
Cardiol Clin; 2024 Aug; 42(3):417-431. PubMed ID: 38910025
[TBL] [Abstract][Full Text] [Related]
20. The Case for Selective Patent Foramen Ovale Closure After Cryptogenic Stroke.
Wiktor DM; Carroll JD
Circ Cardiovasc Interv; 2018 Mar; 11(3):e004152. PubMed ID: 29870380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
